Other: Fed Circuit mandate | Jul 19, 2024 | PAPER | BOARD |
Patent Owner's Notice of Appeal | Jan 10, 2023 | PAPER | PATENT OWNER |
Petitioner's Amended Mandatory Notices | Dec 29, 2022 | PAPER | PETITIONER |
Ex. 3002 | Nov 9, 2022 | EXHIBIT | BOARD |
Final Written Decision: original | Nov 9, 2022 | PAPER | BOARD |
Other: Hearing transcript | Oct 26, 2022 | PAPER | BOARD |
Ex. 2286 - Supplemental Declaration of Doris Weber | Oct 14, 2022 | EXHIBIT | PATENT OWNER |
Petitioner's Amended Mandatory Notices | Sep 29, 2022 | PAPER | PETITIONER |
Petitioner's Amended Mandatory Notices | Aug 23, 2022 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List | Aug 9, 2022 | PAPER | PETITIONER |
Petitioner's Corrected Demonstratives for Oral Argument | Aug 9, 2022 | EXHIBIT | PETITIONER |
Petitioner's Updated Exhibit List | Aug 5, 2022 | PAPER | PETITIONER |
Petitioner's Demonstratives for Oral Argument (IPR2021-00881) | Aug 5, 2022 | EXHIBIT | PETITIONER |
Patent Owner's Demonstratives for Oral Argument | Aug 5, 2022 | EXHIBIT | PATENT OWNER |
Patent Owner's Updated Exhibit List | Aug 5, 2022 | PAPER | PATENT OWNER |
Patent Owner's Reply on Motion to Exclude Evidence | Aug 2, 2022 | PAPER | PATENT OWNER |
Petitioner's Reply to Patent Owner's Opposition to Petitioner's Motion to Exclude | Aug 2, 2022 | PAPER | PETITIONER |
Petitioner's Opposition to Patent Owner's Motion to Exclude | Jul 27, 2022 | PAPER | PETITIONER |
Patent Owner's Opposition to Petitioner's Motion to Exclude Evidence | Jul 27, 2022 | PAPER | PATENT OWNER |
Petitioner's Motion to Seal | Jul 20, 2022 | PAPER | PETITIONER |
Petitioner's Motion to Exclude Evidence CONFIDENTIAL | Jul 20, 2022 | PAPER | PETITIONER |
Petitioner's Motion to Exclude Evidence REDACTED | Jul 20, 2022 | PAPER | PETITIONER |
Patent Owner's Motion to Exclude | Jul 20, 2022 | PAPER | PATENT OWNER |
Petitioner's Amended Mandatory Notices | Jul 18, 2022 | PAPER | PETITIONER |
Order: Granting Request for Oral Hearing | Jul 15, 2022 | PAPER | BOARD |
ORDER Granting Patent Owner's Unopposed Motions for Entry of Default Protective Order and to Seal and Petitioner's Motion to Seal | Jul 13, 2022 | PAPER | BOARD |
Petitioner's Request for Oral Argument | Jul 8, 2022 | PAPER | PETITIONER |
Patent Owner's Request for Oral Argument | Jul 8, 2022 | PAPER | PATENT OWNER |
Patent Owner's Sur-Reply | Jul 6, 2022 | PAPER | PATENT OWNER |
Thomas Albini Deposition Transcript | Jul 6, 2022 | EXHIBIT | PATENT OWNER |
Mary Gerritsen Deposition Transcript | Jul 6, 2022 | EXHIBIT | PATENT OWNER |
CONFIDENTIAL Ivan Hofmann Deposition Transcript | Jul 6, 2022 | EXHIBIT | PATENT OWNER |
PUBLIC Ivan Hofmann Deposition Transcript, part 1 of 3 | Jul 6, 2022 | EXHIBIT | PATENT OWNER |
PUBLIC Ivan Hofmann Deposition Transcript, part 2 of 3 | Jul 6, 2022 | EXHIBIT | PATENT OWNER |
PUBLIC Ivan Hofmann Deposition Transcript, part 3 of 3 | Jul 6, 2022 | EXHIBIT | PATENT OWNER |
Patent Owner's Motion to Seal | Jul 6, 2022 | PAPER | PATENT OWNER |
Order: Granting Petitioners Unopposed Motions for Admission pro hac vice of Robert Cerwinski, Brigid Morris, and Aviv Zalcenstein | Jun 27, 2022 | PAPER | BOARD |
Patent Owner's Notice of Deposition of Dr. Thomas A. Albini | Jun 21, 2022 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Ivan T. Hofmann | Jun 20, 2022 | PAPER | PATENT OWNER |
PETITIONER CELLTRION, INC. UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF ROBERT CERWINSKI UNDER 37 C.F.R. § 42.10(c) | Jun 6, 2022 | PAPER | PETITIONER |
PETITIONER CELLTRION, INC. UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF BRIGID MORRIS UNDER 37 C.F.R. § 42.10(c) | Jun 6, 2022 | PAPER | PETITIONER |
PETITIONER CELLTRION, INC. UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF AVIV ZALCENSTEIN UNDER 37 C.F.R. § 42.10(c) | Jun 6, 2022 | PAPER | PETITIONER |
Patent Owner's Second Set of Objections to Petitioner's Exhibits | Jun 6, 2022 | PAPER | PATENT OWNER |
Patent Owner's Corrected Second Set of Objections to Petitioner's Exhibits | Jun 6, 2022 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Mary E. Gerritsen, Ph.D. | Jun 6, 2022 | PAPER | PATENT OWNER |
Petitioner Celltrion's Updated Exhibit List | May 31, 2022 | PAPER | PETITIONER |
Declaration of Robert V. Cerwinski ISO Motion for Pro Hac Vice Admission | May 31, 2022 | EXHIBIT | PETITIONER |
Declaration of Aviv A. Zalcenstein ISO Motion for Pro Hac Vice Admission | May 31, 2022 | EXHIBIT | PETITIONER |
Declaration of Brigid M. Morris ISO Motion for Pro Hac Vice Admission | May 31, 2022 | EXHIBIT | PETITIONER |
Petitioner's Motion to Seal (5-27-22) | May 27, 2022 | PAPER | PETITIONER |
Ex. 1102 - '959 FH, 12-22-2011 PTE | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1103 - Klibanov Dep. Ex. 3, Klibanov Amgen Decl. | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1104 - Klibanov Dep. Ex. 18, Hanhart | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1105 - Klibanov Dep. Ex. 19, Stefanini | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1106 - Klibanov Dep. Ex. 20, Yang | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1107 - Klibanov Dep. Ex. 22, WHO Drug Info | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1108 - Klibanov Dep. Tr. CONFIDENTIAL | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1108 - Klibanov Dep. Tr. REDACTED | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1109 - Do Dep. Tr. | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1110 - Brown Dep. Tr. | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1111 - Del Priore Dep. Tr. CONFIDENTIAL | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1111 - Del Priore Dep. Tr. REDACTED | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1112 - Klibanov Dep. Ex. 14, Duncan | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1113 - Del Priore Dep. Ex. 10, Rudge 2008 | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1114 - Albini Reply Decl. | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1115 - Gerritsen Reply Decl. | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1116 - Transcript (19-May-2022) | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1117 - Klibanov Dep. Ex. 6, ���173 patent SEQ. ID No 2 | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1118 - Klibanov Dep. Ex. 9, CAS | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1119 - Klibanov Dep. Ex. 12, Rudge 2007 | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1120 - Klibanov Dep. Ex. 13, Gomez-Manzano | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1121 - Klibanov Dep. Ex. 21, Liu | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1122 - AA Alignment | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1123 - Quiram | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1124 - NA Alignment | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1125 - HPE 2006 | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1126 - Volkin & Klibanov 1992 | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1127 - 959 FH, Election re PTE | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1128 - 959 FH, PTE Certificate | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1129 - Wulff | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1130 - Do Dep. Ex. 2, Regeneron (22-Nov-2019) | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1131 - Do Dep. Ex. 3, Vanderkam | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1133 - '345 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1134 - '601 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1135 - '058 publication | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1136 - Hofmann CV | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1137 - Hofmann Reply Decl. CONFIDENTIAL | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1137 - Hofmann Reply Decl. REDACTED | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1138 - Do Dep. Ex. 4, ���338 patent claim 1 | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1139 - Brown Dep. Ex. 10, ASRS Clinical Update | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1140 - Brown Dep. Ex. 11, Medicare Comment Summary | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1141 - PGR20221-00035, Paper 6 | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1142 - Fauser | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1143 - Do | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1144 - '563 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1145 - '653 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1146 - Drugs@FDA_ Eylea | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1147 - Regeneron 2005 10-K | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1148 - '748 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1149 - Regeneron 2011 10-K | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1150 - Weber Dep. Tr. | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1151 - Manning Dep. Tr. CONFIDENTIAL | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1151 - Manning Tr. REDACTED | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1152 - Manning Dep. Ex. 6, Eylea Label 06.2021 | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1153 - Manning Dep. Ex. 7, Eylea Patent List | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1154 - 2020-06-24 Complaint | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1155 - Batta | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1156 - Eylea Label 05.2016 | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1157 - '261 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1158 - '598 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1159 - '791 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1160 - '803 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1161 - '737 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1162 - '842 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1163 - '992 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1164 - '458 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1165 - '865 patent | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1166 - Purple Book List | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1167 - United Healthcare Ophthalmologic Policy, VEGF | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1168 - BCBS Florida VEGF | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1169 - Eylea Summary Review | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1170 - mygoodays.org CDF | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1171 - Official EYLEA (aflibercept) Injection Website | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1172 - Bayer and Regeneron to Collaborate on VEGF Trap | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1173 - Complaint, Horizon v Regeneron, 2022-04 | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1174 - oig.hhs.gov Publication of OIG Special Fraud Alerts | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1175 - MorganLewis - New Purple Book Patent Requirements | May 27, 2022 | EXHIBIT | PETITIONER |
Ex. 1176 - Dadgostar | May 27, 2022 | EXHIBIT | PETITIONER |
Petitioner's Reply (CONFIDENTIAL) | May 27, 2022 | PAPER | PETITIONER |
Petitioner's Reply (REDACTED) | May 27, 2022 | PAPER | PETITIONER |
Petitioner's Amended Mandatory Notices | May 16, 2022 | PAPER | PETITIONER |
Order: Other | May 11, 2022 | PAPER | BOARD |
Petitioner's Notice of Deposition of Doris Weber | May 3, 2022 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Richard Manning Ph.D. | Apr 22, 2022 | PAPER | PETITIONER |
Petitioner's Unopposed Motion for Pro Hac Vice Admission of Eric R. Hunt | Apr 20, 2022 | PAPER | PETITIONER |
Declaration of Eric R. Hunt in Support of Petitioner's Unopposed Motion for Pro Hac Vice Admission | Apr 20, 2022 | EXHIBIT | PETITIONER |
Petitioner's Updated Exhibit List | Apr 20, 2022 | PAPER | PETITIONER |
Petitioner's Updated Power of Attorney | Apr 20, 2022 | PAPER | PETITIONER |
Petitioner's Amended Mandatory Notices | Apr 20, 2022 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Lucian V. Del Priore M.D. Ph.D. | Apr 19, 2022 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of David M. Brown M.D. | Apr 15, 2022 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Diana V. Do M.D. | Apr 11, 2022 | PAPER | PETITIONER |
Order: Revised Joint Scheduling Order | Mar 23, 2022 | PAPER | BOARD |
Petitioners Notice of Deposition of Alexander M. Klibanov Ph.D, | Mar 14, 2022 | PAPER | PETITIONER |
Patent Owner's Response to Petitioner's Identification of Statements Supported by Objected to References in Patent Owner Responses | Mar 3, 2022 | PAPER | PATENT OWNER |
PETITIONER'S IDENTIFICATION OF STATEMENTS SUPPORTED BY OBJECTED TO REFERENCES IN PATENT OWNER RESPONSES | Feb 28, 2022 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List | Feb 28, 2022 | PAPER | PETITIONER |
Ex. 1100 - Transcript (23-February-2022) | Feb 28, 2022 | EXHIBIT | PETITIONER |
Petitioner's Second Objections to Patent Owner's Exhibits | Feb 18, 2022 | PAPER | PETITIONER |
Corrected Patent Owner's Motion to Seal | Feb 14, 2022 | PAPER | PATENT OWNER |
EXPUNGED | Feb 11, 2022 | PAPER | PATENT OWNER |
Declaration of Lucian V. Del Priore, M.D., Ph.D. - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Lucian V. Del Priore, M.D., Ph.D. - Public Version | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Alexander M. Klibanov, Ph.D. - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Alexander M. Klibanov, Ph.D. - Public Version | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Declaration of David M. Brown, M.D. | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Diana V. Do, M.D. | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Richard Manning, Ph.D. with Attachments - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Declaration of Richard Manning, Ph.D. with Attachments - Public Version | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
NCT00794417 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
NCT01148615 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Ferrara 2006 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Kim 2012 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Ramazi 2021 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Bork 2009 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Koehler-Stec Report - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
VGFT-OD-0605 Analysis Summary - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Kim 2021 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Nieto 2013 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Fernandez-Ferreiro 2017 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Shen 2007 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Cobo 1981 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Pflugfelder 1987 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Hirokawa 1988 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Prange 1998 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Kleiger 2000 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Demarest 2004 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Kuhlmann 2010 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Murphy 2006 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Zaltrap non-comparability - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Sola 2009 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Approval Letter | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Cantu 2010 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Chen 2016 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
NCT00519285 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
NCT00644124 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Heier Retinal Physician 2009 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
CV of Lucian V. Del Priore, M.D., Ph.D. | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
CV of Alexander M. Klibanov, Ph.D. | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
CV of David M. Brown, M.D. | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Adamis Chapter 4 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Brown 2009 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regillo 2008 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Abraham 2010 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Barbazetto 2010 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Cruz 2006 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Retinal Physician Symposium | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Lucentis Label 2006 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Schmidt-Erfuth 2011 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Margolis 2010 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Brown 2011 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Heier 2011 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Research Agreement - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
FDA Non-Inferiority Clinical Trials | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
CDER Statistical Review | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
FDA 22 Case Studies | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Heier 2005 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
NCT00320788 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Wells 2015 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Retinal Physician - Ongoing Treatment | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Mathis 2009 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Cousins 2010 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Helzner 2007 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Press Release Nov. 18, 2011 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
FDA Expedited Programs | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
NCT01486771 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Gallemore 2008 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Kanghong Press Release - Chinese | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Kanghong Press Release - English Translation | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Thomas 2013 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Ohr 2012 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
FDA Approves Eylea for Wet AMD | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Corrected Press Release Nov. 18, 2011 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Macugen Approval Letter | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Brown 2006 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Rosenfeld 2006 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Genentech Press Release Dec. 30, 2005 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Genentech Press Release June 30, 2006 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
NCT00473330 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
NCT00473382 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
NCT00486018 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
NCT00485836 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
NCT00943072 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
NCT01012973 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
VGFT-OD-0605 Protocol Signature Page - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Transcript of Deposition of Mary Gerritsen Ph.D., Jan. 14, 2022 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Transcript of Deposition of Thomas Albini M.D., Jan. 20, 2022 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Brown 2013 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Albini Deposition Exhibit 14 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Earnings Call Transcript, Feb. 13, 2012 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Earnings Call Transcript, Apr. 26, 2012 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Earnings Call Transcript, July 25, 2012 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Marketing Material, 2013 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Marketing Material, Nov. 2013 part 1 of 2 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Marketing Material Nov. 2013 part 2 of 2 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Physician ATU Wave 2 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron For the Treatment of Wet AMD, 2012 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Physician ATU Wave 5 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Am. Acad. of Ophthalmol. - Anti-VEGF Treatments | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Am. Acad. of Ophthalmol. - Bevacizumab | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Am. Acad. of Ophthalmol. - Ophthalmology Subspecialists | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Am. Acad. of Ophthalmol. - Retinal Vasculitis | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Am. Acad. of Ophthalmol. - What Is Avastin | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Am. Acad. of Ophthalmol. - What Is Eylea | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Am. Acad. of Ophthalmol. - What Is Lucentis | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Am. Soc. of Retina Specialists - About Us | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Am. Soc. of Retina Specialists - Age-Related Macular Degeneration | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Am. Soc. of Retina Specialists - Branch Retinal Vein Occlusion | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Am. Soc. of Retina Specialists - Central Retinal Vein Occlusion | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Am. Soc. of Retina Specialists - Diabetic Retinopathy | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Amgen - Fusion Protein | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
ASHA - Calculating Medicare Fee Schedule Rates | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
ASPE Issue Brief - Medicare Part B Reimbursement of Prescription Drugs | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Avastin Drug Label 2004 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Base Pair Biotechnologies - What is an Aptamer | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Bausch and Lomb Website - Visudyne | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Bausch and Lomb Website - Visudyne Saftey Information | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Bausch Health Companies 10-K, 2020 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Beovu Drug Label Oct. 2019 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Beovu Drug Label June 2020 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Physician ATU Wave 4 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
BrightFocus Foundation - AMD Facts & Figures | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Brookings - Medicare Payment for Physician-Administered (Part B) Drugs | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Calculator.net - Sample Size Calculator | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
CDC - Vision Loss - A Public Health Problem | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Centers for Medicare & Medicaid Services Data - Practitioners | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Sample Disbursement part 1 of 6 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Sample Disbursement part 2 of 6 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Sample Disbursement part 3 of 6 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Sample Disbursement part 4 of 6 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Sample Disbursement part 5 of 6 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Sample Disbursement part 6 of 6 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
US Eylea P&L - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
US Eylea P&L - Public Version | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
CloudResearch - Determining Sample Size | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
CMS - 2021 ASP Drug Pricing Files | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
CMS - Medicare Part B Drug Average Sales Price | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
CMS - Physician Fee Schedule | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
CMS Medicare Coverage Database - Billing and Coding Afilbercept | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Q4 Performance Update - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Donahue 2007 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Donohue 2004 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Dreyfuss 2015 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Miller 2020 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Drugs.com - Eylea FDA Approval History | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Elyasi 2021 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eye Care Surgery Center - Macular Degeneration | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
EyeGuru - Intravitreal Injection Standard Dosing Table | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Drug Label Nov. 2011 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Drug Label Sept. 2012 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Drug Label Oct. 2014 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Drug Label May 2019 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Drug Label Mar. 2021 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Website - Dosing Flexibility for Wet AMD | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
FDA Website - Drug Approval Package Macugen | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
FiercePharma - Beovu, Novartis | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
FiercePharma - Novartis Drug Beovu Tied to Potential Vision Loss | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
FiercePharma - The top 20 drugs by worldwide sales in 2020 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
FocusVision - Survey Sample Size How Much Do I Need | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Gagnon 2008 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Physician ATU Benchmark Wave - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
GEN - FDA Green-Lights Genentechs Lucentis | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Genentech Press Release June 30, 2006 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron US Eylea Historical PL - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron US Eylea Historical PL - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron US Eylea Historical PL - Public | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Guha 2009 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
HCPCS Codes - HCPCS Codes | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Healio - Access to retina providers shows no geographic bias in US | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Hopkins Medicine Website - Photodynamic Therapy for AMD | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea DME Market Assessment - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
IQVIA 10-K 2020 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
IQVIA - Available IQVIA Data | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea ATU Wave 2 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
KFF - Snapshot of Sources of Coverage | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
KFF - Medicare Advantage in 2021 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Ling 2002 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Lucentis Drug Label 2006 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Lucentis Drug Label June 2010 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Lucentis Drug Label Aug. 2012 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Lucentis Drug Label Apr. 2017 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Lucentis Drug Label Mar. 2018 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Macugen Drug Label Dec. 2004 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Components of Reimbursement - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Components of Reimbursement - Public | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Mankiw Chapter 1 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Manning 2015 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Mayo Clinic - Wet macular degeneration - Diagnosis and treatment | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Mayo Clinic - Wet macular degeneration - Symptoms and Causes | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Medicare Interactive - Medicare Part B Covered Services | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Medicare Interactive - The parts of Medicare | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Medicare.gov - Macular Degeneration Coverage | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Medicare.gov - Medicare Advantage Plans | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Medicare.gov - When does Medicare coverage start | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
MedlinePlus Medical Encyclopedia - Laser photocoagulation | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron WAC Pricing - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Novartis - Annual Report, 2020 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Novartis Press Release Oct. 8, 2019 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Novartis Press Release June 11, 2020 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Oct 12 ASP Pricing File revised 060513 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Oct 13 ASP Pricing File updated 060614 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Oct 15 ASP Pricing File - updated 120915 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Oct 16 ASP Pricing File updated 082817 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Oct 17 ASP Pricing File 083017 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Oct 18 ASP Pricing File updated 052919 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Oct 2019 ASP Pricing File 052920 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Oct 14 ASP Pricing File - revised 090115 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
October 2020 ASP Pricing File updated 090121 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
October 2021 ASP Pricing File updated 011022 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
ASRS Preferences & Trends Survey 2016 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
ASRS Preferences & Trends Survey 2015 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Pindyck Chapter 3 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron - About Us | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Press Release July 29, 2014 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Press Release Oct. 6, 2014 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Press Release May 13, 2019 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
ASRS Preferences & Trends Survey 2014 part 1 of 2 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
ASRS Preferences & Trends Survey 2014 part 2 of 2 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron - History | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Press Release Sept. 21, 2012 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron - Research Areas | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Form 10-K for 2020 part 1 of 2 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Form 10-K for 2020 part 2 of 2 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Retinal Physician - Revisiting an Early Treatment for Wet AMD | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Roche 10-K, 2020 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Roche Press Release Aug. 13, 2012 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Roche Press Release Apr. 18, 2017 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
ASRS Preferences & Trends Survey 2009 - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Schweitzer Chapter 4 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
ScienceDaily - FDA Approves First Angiogenesis Inhibitor | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Sivaprasad 2021 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Sales Summary - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Verywell Health - Maclular Degeneration Timeline | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Vestrum Health - Explore what we can do for you | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Vestrum Health - Pharmaceutical companies | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Visudyne Drug Label Apr. 2016 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Weidner 2021 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
WHO - Blindness and vision impairment | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Yahoo Finance - Beovu Now Publicly Reimbursed | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Yorston 2014 | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Q2 2021 Performance - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Vestrum Anti-VEGF Category Sales Shares - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Wet AMD Line of Therapy Insights - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Vestrum Anti-VEGF Market Share Adjustment - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Q2 2020 Performance - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Marketing Planning Process - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron Wave 1 2021 Performance Update - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron ATU Sales Share Data - All Indications | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron ATU Sales Share Data - Wet AMD | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron ATU Sales Share Data - DME | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron ATU Sales Share Data - CRVO | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron ATU Sales Share Data - BRVO | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Regeneron ATU Sales Share Data - DR without DME | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Gross & Net Sales P&L - Confidential | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
Eylea Gross & Net Sales P&L - Public | Feb 11, 2022 | EXHIBIT | PATENT OWNER |
EXPUNGED | Feb 11, 2022 | PAPER | PATENT OWNER |
EXPUNGED | Feb 11, 2022 | PAPER | PATENT OWNER |
Corrected Patent Owner Response - Confidential | Feb 11, 2022 | PAPER | PATENT OWNER |
Corrected Patent Owner Response - Public | Feb 11, 2022 | PAPER | PATENT OWNER |
Other: DECISION Granting Institution of Inter Partes Review Granting Motion for Joinder | Feb 9, 2022 | PAPER | BOARD |
Other: DECISION Granting Institution of Inter Partes Review Granting Motion for Joinder | Feb 9, 2022 | PAPER | BOARD |
EXPUNGED | Feb 7, 2022 | EXHIBIT | BOARD |
Patent Owner's Unopposed Motion for Entry of Default Protective Order | Feb 3, 2022 | PAPER | PATENT OWNER |
Notice of Stipulated Schedule | Dec 9, 2021 | PAPER | PATENT OWNER |
Granting Patent Owners Unopposed Motions for Admission pro hac vice of Victoria Reines, Daniel Reisner, Matthew M. Wilk, and Jeremy Cobb 37 C.F.R. sec 42.10 | Dec 9, 2021 | PAPER | BOARD |
Petitioner's Objections to Patent Owner's Exhibits | Nov 26, 2021 | PAPER | PETITIONER |
Patent Owner's Objections to Petitioner's Exhibits | Nov 24, 2021 | PAPER | PATENT OWNER |
Patent Owner's Power of Attorney | Nov 22, 2021 | PAPER | PATENT OWNER |
Patent Owner's Updated Mandatory Notices | Nov 22, 2021 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Nov 22, 2021 | PAPER | PATENT OWNER |
Pro Hac Vice Motion to Admit Victoria Reines | Nov 22, 2021 | PAPER | PATENT OWNER |
Declaration of Victoria Reines | Nov 22, 2021 | EXHIBIT | PATENT OWNER |
Pro Hac Vice Motion to Admit Daniel Reisner | Nov 22, 2021 | PAPER | PATENT OWNER |
Declaration of Daniel Reisner | Nov 22, 2021 | EXHIBIT | PATENT OWNER |
Pro Hac Vice Motion to Admit Matthew M. Wilk | Nov 22, 2021 | PAPER | PATENT OWNER |
Declaration of Matthew M. Wilk | Nov 22, 2021 | EXHIBIT | PATENT OWNER |
Pro Hac Vice Motion to Admit Jeremy Cobb | Nov 22, 2021 | PAPER | PATENT OWNER |
Declaration of Jeremy Cobb | Nov 22, 2021 | EXHIBIT | PATENT OWNER |
Order: JOINT SCHEDULING ORDER | Nov 12, 2021 | PAPER | BOARD |
Institution Decision: Grant | Nov 10, 2021 | PAPER | BOARD |
Patent Owner's Consolidated Sur-reply to Reply to Preliminary Response | Oct 6, 2021 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | Oct 6, 2021 | PAPER | PATENT OWNER |
Thomson Reuters Press Release | Oct 6, 2021 | EXHIBIT | PATENT OWNER |
Petitioner's Amended Mandatory Notices | Oct 1, 2021 | PAPER | PETITIONER |
Mylan Reply to POPR | Sep 29, 2021 | PAPER | PETITIONER |
Petitioner���s Updated Exhibit List | Sep 29, 2021 | PAPER | PETITIONER |
Ex.1098 - Redline Compare | Sep 29, 2021 | EXHIBIT | PETITIONER |
Ex.1099 - 597 FH Excerpts (NXP) | Sep 29, 2021 | EXHIBIT | PETITIONER |
Patent Owner's Updated Mandatory Notices | Sep 24, 2021 | PAPER | PATENT OWNER |
Order: Additional Briefing | Sep 22, 2021 | PAPER | BOARD |
Order: on Motion | Sep 22, 2021 | PAPER | BOARD |
Mylan Pharmaceuticals Inc.���s Unopposed Motion to Amend Its Mandatory Notices | Sep 14, 2021 | PAPER | PETITIONER |
Petitioner's Updated Exhibit List | Sep 10, 2021 | PAPER | PETITIONER |
Ex. 1097 - Transcript (8-September-2021) | Sep 10, 2021 | EXHIBIT | PETITIONER |
Expert Declaration of Dr. Diana V. Do, M.D. | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Curriculum Vitae of Dr. Diana Do | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Lucentis (ranibzumab injection) label, revised June 2010 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Tender Offer to Momenta | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Press Release, Aug. 19, 2020 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Press Release, Oct. 1, 2020 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Press Release, Sept. 28, 2008 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
NCT00637337 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
US Patent App. Pub. 2006/0058234 A1 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Excerpts from Biochemistry 5th Ed. | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Stewart & Rosenfeld 2008 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Iacono 2010 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Do 2009 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Mononey 2009 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
US Patent App. Pub. 2010/0160233 A1 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Hachiya 2007 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Piques 2009 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Jaffe 2016 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Eylea (aflibercept) Injection label, revised May 2016 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
NCT02247531 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
NCT02247479 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
NCT03630952 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
NCT03577899 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
NCT01944839 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
NCT01940900 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
BiopharmaDive article, Aug. 14, 2017 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Li 2014 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Presentation, Sept. 30, 2007 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Bhisitkul & Stewart 2010 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Park 2012 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Spaide 2007 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Boyer 2009 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Lucentis (ranibzumab injection) label, revised March 2018 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
US Patent 7,303,746 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
US Patent 7,521,049 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
US Patent 7,303,747 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
US Patent 7,306,799 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Macugen (pegaptanib sodium injection) label | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Press Release, Feb. 14, 2013 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Press Release, Feb. 6, 2020 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Press Release, Dec. 20, 2010 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Levine 2009 | Aug 16, 2021 | EXHIBIT | PATENT OWNER |
Preliminary Response of Patent Owner Regeneron Pharmaceuticals, Inc. | Aug 16, 2021 | PAPER | PATENT OWNER |
DECISION
Granting Petitioners Motions for Admission pro hac vice of William A. Rakoczy and Heinz J. Salmen 37 C.F.R. sec 42.10 | Jul 22, 2021 | PAPER | BOARD |
Mylan Pharmaceuticals Inc.���s Unopposed Motion For Pro Hac Vice Admission Of William A. Rakoczy | Jun 18, 2021 | PAPER | PETITIONER |
Ex.1095 - WAR Declaration (PHV Admission) - 338 petition (6-18-21) | Jun 18, 2021 | EXHIBIT | PETITIONER |
Mylan Pharmaceuticals Inc.���s Unopposed Motion For Pro Hac Vice Admission Of Heinz J. Salmen | Jun 18, 2021 | PAPER | PETITIONER |
Ex.1096 - HJS Declaration (PHV Admission) - 338 petition (6-18-21) | Jun 18, 2021 | EXHIBIT | PETITIONER |
Petitioner���s Exhibit List - 338 petition (6-18-21) | Jun 18, 2021 | PAPER | PETITIONER |
Patent Owner's Power of Attorney | May 24, 2021 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notices | May 24, 2021 | PAPER | PATENT OWNER |
Notice of Accord Filing Date | May 14, 2021 | PAPER | BOARD |
Ex.1001 - 338 patent | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1002 - Albini | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1003 - Gerritsen | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1004 - Holash | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1005 - Nguyen-2009 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1006 - Dixon | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1007 - Adis | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1008 - 173 patent | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1009 - 664 patent | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1010 - 758 patent | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1011 - Semeraro | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1012 - Regeneron (28-April-2008) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1013 - Regeneron (8-May-2008) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1014 - NCT-795 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1015 - NCT-377 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1016 - Monthly-Dosing-Patents | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1017 - 338 FH | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1018 - Heier-2012 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1019 - 069 patent | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1020 - Heier-2009 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1021 - 2009 10-Q | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1022 - 757 patent | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1023 - 959 patent | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1024 - 758 FH - 12-22-2011 PTE | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1025 - Engelbert-2010 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1026 - Engelbert-2009 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1027 - Spaide | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1028 - Regeneron (30-April-2009) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1029 - NCT-973 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1030 - Mitchell | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1031 - Massin | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1032 - Bayer (8-May-2008) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1033 - Dix | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1034 - Fung | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1035 - Lalwani | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1036 - Campochiaro | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1037 - Steinbrook | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1038 - Albini CV | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1039 - 095 patent | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1040 - WHO Drug Info | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1041 - Regeneron (26-February-2009) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1042 - NIH AMD | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1043 - Brown | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1044 - NIH DR | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1045 - Ferrara-1999 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1046 - Ferrara-2005 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1047 - Bashshur | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1048 - Lucentis | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1049 - Spielberg | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1050 - Schmidt-Erfuth | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1051 - Keane | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1052 - Rudge | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1053 - Regeneron (27-March-2007) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1054 - Regeneron (2-August-2007) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1055 - Retina Society Meeting Presentation | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1056 - Regeneron (28-September-2008) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1057 - Regeneron (18-February-2010) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1058 - ARVONews Winter-Spring 2008 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1059 - ARVONews Summer 2007 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1060 - Korobelnik | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1061 - Gerritsen CV | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1062 - EP-325 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1063 - EP-325-FH | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1064 - Wayback-BJO-Online First | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1065 - BJO-Article Metrics | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1066 - Bayer (18-February-2010) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1067 - Bayer (28-April-2008) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1068 - Regeneron (14-September-2009) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1069 - Background-ClinicalTrials.gov | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1070 - Wayback-Affidavit (069) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1071 - Holz | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1072 - Reichert | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1073 - Anderson | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1074 - Ciulla | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1075 - Ni | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1076 - Zarbin | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1077 - Corporate Finance Institute | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1078 - Schneider | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1079 - Kuepper | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1080 - Zucchi | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1081 - Hayes | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1082 - 069 amino acid sequences | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1083 - 069 nucleotide sequences | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1084 - Weigand | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1085 - Shams | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1086 - History-ClinicalTrials.gov | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1087 - Wayback Affidavit (338) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1088 - Nguyen-2006 | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1089 - Regeneron (19-August-2008) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1090 - Kim | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1091 - Eylea PI | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1092 - Bayer (19-August-2008) | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1093 - 338 amino acid sequences | May 5, 2021 | EXHIBIT | PETITIONER |
Ex.1094 - 338 nucleotide sequences | May 5, 2021 | EXHIBIT | PETITIONER |
Petition | May 5, 2021 | PAPER | PETITIONER |
Power of Attorney | May 5, 2021 | PAPER | PETITIONER |